DISCLOSEDQuarterly
Polen Capital Management
Denali Therapeutics Inc · NASDAQ
65,301 sh · $1.3M
Filed 31 Mar 2026SEC 13Fview source
Polen Capital Management
Denali Therapeutics Inc · NASDAQ
65,301 sh · $1.3M
Polen Capital Management
Denali Therapeutics Inc · NASDAQ
26,900 sh · $444.1K
BlackRock
Denali Therapeutics Inc · NASDAQ
13,174,562 sh · $305.9M